Basic Description:

Hydroxycarbamide - Hydroxyurea - Not Specifically NF2 - Treatment for Meningiomas - Discontinued? "Hydroxycarbamide previously called, Hydroxyurea (INN) or hydroxyurea (brand names include Hydrea and Droxia) is an antineoplastic drug, first synthesized in 1869, used in myeloproliferative disorders, specifically polycythemia vera and essential thrombocythemia." - Wikipedia

NF2 Trial:

• Ph I Zactima + Imatinib Mesylate & Hydroxyurea for Pts w Recurrent MG - www.ClinicalTrials.gov
• Phase II Study of GIVINOSTAT (ITF2357) in Combination With Hydroxyurea in Polycythemia Vera (PV) - www.ClinicalTrials.gov
• Ph I Gleevec in Combo w RAD001 + Hydroxyurea for Pts w Recurrent MG - www.ClinicalTrials.gov
• Study of Imatinib Mesylate in Combination With Hydroxyurea Versus Hydroxyurea Alone as an Oral Therapy in Patients With Temozolomide Resistant Progressive Glioblastoma - www.ClinicalTrials.gov

NF2 NYC Support Group, New York
Email: Lori Davila at lori@nf2nycsupport.org
Copyright © 2008 - 2012

DISCLAIMER: www.nf2nycsupport.org is not run by medical experts, affiliated with any healthcare organization or any other company. No assurance can be made to the accuracy or completeness of the information provided here, the accuracy of other sites to which this site links, or of sites that link to this site. While we hope the information found on the www.nf2nycsupport.org site is helpful in offering suggestions in topics to discuss with your doctor, information found here should not be considered actual medical advice. Medical advice should always be sought by consultation with a medical professional.